Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Malkin

Showing results (91-100 of 270) with videos related to

Pageof 27
Sort By:
Pediatric Blood & Cancer|May 24, 2024
Cost-effectiveness of the McGill interactive pediatric oncogenetic guidelines in identifying Li-Fraumeni syndrome in female patients with osteosarcomaJuan David Rios, Frances Simbulan, Lara Reichman, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2008
Excessive genomic DNA copy number variation in the Li-Fraumeni cancer predisposition syndromeAdam Shlien, Uri Tabori, Christian R Marshall, et al.
Journal of Pediatric Hematology/Oncology|December 8, 2025
Parent and Patient Proxies' Preferences on Whole-body MRI Techniques for Cancer Predisposition Syndromes' SurveillanceSayali Joshi, Rahim Moineddin, Paul C Nathan, et al.
Journal of Pediatric Hematology/Oncology|August 26, 2024
Patterns of Growth of Tumors in Li-Fraumeni Syndrome by Imaging: A Case SeriesRoxana Azma, Jesus Arenos-Abril, Thitiporn Junhasavasdiku, et al.
American Journal of Human Genetics|September 19, 2024
International policies guiding the selection, analysis, and clinical management of secondary findings from genomic sequencing: A systematic reviewSafa Majeed, Christine Johnston, Saumeh Saeedi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2014
Impact of craniospinal dose, boost volume, and neurologic complications on intellectual outcome in patients with medulloblastomaIska Moxon-Emre, Eric Bouffet, Michael D Taylor, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 2, 2013
Attitudes of Canadian researchers toward the return to participants of incidental and targeted genomic findings obtained in a pediatric research settingConrad V Fernandez, Caron Strahlendorf, Denise Avard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
A phase I and pharmacokinetic study of ecteinascidin-743 (Yondelis) in children with refractory solid tumors. A Children's Oncology Group studyLoretta Lau, Jeffery G Supko, Susan Blaney, et al.
Cancer|January 3, 2014
Anaplastic rhabdomyosarcoma in TP53 germline mutation carriersSimone Hettmer, Natasha M Archer, Gino R Somers, et al.
JAMA Network Open|June 4, 2025
Detecting and Remediating Harmful Data Shifts for the Responsible Deployment of Clinical AI ModelsVallijah Subasri, Amrit Krishnan, Ali Kore, et al.
Pageof 27

Showing results (91-100 of 270) with videos related to

Sort By:
Pageof 27
Pediatric Blood & Cancer|May 24, 2024
Cost-effectiveness of the McGill interactive pediatric oncogenetic guidelines in identifying Li-Fraumeni syndrome in female patients with osteosarcomaJuan David Rios, Frances Simbulan, Lara Reichman, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2008
Excessive genomic DNA copy number variation in the Li-Fraumeni cancer predisposition syndromeAdam Shlien, Uri Tabori, Christian R Marshall, et al.
Journal of Pediatric Hematology/Oncology|December 8, 2025
Parent and Patient Proxies' Preferences on Whole-body MRI Techniques for Cancer Predisposition Syndromes' SurveillanceSayali Joshi, Rahim Moineddin, Paul C Nathan, et al.
Journal of Pediatric Hematology/Oncology|August 26, 2024
Patterns of Growth of Tumors in Li-Fraumeni Syndrome by Imaging: A Case SeriesRoxana Azma, Jesus Arenos-Abril, Thitiporn Junhasavasdiku, et al.
American Journal of Human Genetics|September 19, 2024
International policies guiding the selection, analysis, and clinical management of secondary findings from genomic sequencing: A systematic reviewSafa Majeed, Christine Johnston, Saumeh Saeedi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2014
Impact of craniospinal dose, boost volume, and neurologic complications on intellectual outcome in patients with medulloblastomaIska Moxon-Emre, Eric Bouffet, Michael D Taylor, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 2, 2013
Attitudes of Canadian researchers toward the return to participants of incidental and targeted genomic findings obtained in a pediatric research settingConrad V Fernandez, Caron Strahlendorf, Denise Avard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
A phase I and pharmacokinetic study of ecteinascidin-743 (Yondelis) in children with refractory solid tumors. A Children's Oncology Group studyLoretta Lau, Jeffery G Supko, Susan Blaney, et al.
Cancer|January 3, 2014
Anaplastic rhabdomyosarcoma in TP53 germline mutation carriersSimone Hettmer, Natasha M Archer, Gino R Somers, et al.
JAMA Network Open|June 4, 2025
Detecting and Remediating Harmful Data Shifts for the Responsible Deployment of Clinical AI ModelsVallijah Subasri, Amrit Krishnan, Ali Kore, et al.
Pageof 27